Genetic Testing to Predict Weight Loss and Diabetes Remission and Long-Term Sustainability after Bariatric Surgery: A Pilot Study

Visualitza/ Obre
Data de publicació
2019Autor/a
Ciudin, Andreea
Fidilio, Enzamaria
Ortiz, Angel
Pich, Sara
Salas, Eduardo
Mesa, Jordi
Hernández, Cristina
Simó-Servat, Olga
Citació recomanada
Ciudin, Andreea;
Fidilio, Enzamaria;
Ortiz, Angel;
Pich, Sara;
Salas, Eduardo;
Mesa, Jordi;
...
Lecube Torelló, Albert.
(2019)
.
Genetic Testing to Predict Weight Loss and Diabetes Remission and Long-Term Sustainability after Bariatric Surgery: A Pilot Study.
Journal of Clinical Medicine, 2019, vol. 8, núm. 7, p. 964.
https://doi.org/10.1186/s12933-019-0897-y.
Metadades
Mostra el registre d'unitat completResum
Introduction: The aim of this pilot study was to assess genetic predisposition risk scores (GPS) in type 2 diabetic and non-diabetic patients in order to predict the better response to bariatric surgery (BS) in terms of either weight loss or diabetes remission.
Research design and methods: A case-control study in which 96 females (47 with type 2 diabetes) underwent Roux-en-Y gastric by-pass were included. The DNA was extracted from saliva samples and SNPs were examined and grouped into 3 GPS. ROC curves were used to calculate sensitivity and specificity.
Results: A highly sensitive and specific predictive model of response to BS was obtained by combining the GPS in non-diabetic subjects. This combination was different in diabetic subjects and highly predictive of diabetes remission. Additionally, the model was able to predict the weight regain and type 2 diabetes relapse after 5 years' follow-up.
Conclusions: Genetic testing is a simple, reliable and useful tool for implementing personalized medicine in type 2 diabetic patients requiring BS.
És part de
Journal of Clinical Medicine, 2019, vol. 8, núm. 7, p. 964Projectes de recerca europeus
Col·leccions
Els fitxers de llicència següents estan associats amb aquest element: